[8] In 2024, the FDA also approved Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with established cardiovascular disease and either obesity or overweight
Whether you choose compounded semaglutide injection, oral formulations, or explore our GLP-Squared dual-compound option, genetic insight supports a personalized treatment conversation that prioritizes both efficacy and sustainable adherence
October 25th, 2024 by Dina Eliopoulos In the era of semaglutide injections like Ozempic, Wegovy, and Rybelsus, these weight loss solutions have gained incredible popularity for their speed in helping you shed unwanted pounds
2022;15:1430 Lewis AL, McEntee N, Holland J, Patel A
Constipation is also common, reported in around 24% of users across clinical trial populations
Fatigue is a possible side effect of semaglutide treatment, and some people may feel more tired than usual especially as their body adjusts to the medication